Tenecteplase Before Interhospital Transfer in Acute Basilar Artery Occlusion at 4.5 to 24 Hours

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

506

Participants

Timeline

Start Date

November 1, 2025

Primary Completion Date

March 31, 2027

Study Completion Date

March 31, 2027

Conditions
Acute Ischemic StrokeBasilar Artery Occlusion
Interventions
DRUG

Tenecteplase thrombolysis

Patients will receive intravenous Tenecteplase 0.25 mg/kg body-weight up to a maximum of 25mg before the transfer. A single bolus dose should be administered over 5-10 seconds based on patient weight. Transfer to ECCs for thrombectomy should be initiated immediately after Tenecteplase administration.

Trial Locations (1)

Unknown

Xuanwu Hospital, Capital Medical University, Beijing

All Listed Sponsors
lead

Xuanwu Hospital, Beijing

OTHER